Parameter | Phase 1(Case #1–34) | Phase 2(Case #35–41) | Phase 3(Case #42–112) | P |
---|---|---|---|---|
Intraoperative | ||||
Pancreatic texture [n (%)] | 0.958* | |||
Soft pancreas97 | 29(85.29%) | 6(85.71%) | 62 | |
Not-soft pancreas15 | 5(14.71%) | 1(14.29%) | 9 | |
MPD size(cm) a | 0.3 | 0.3 | 0.3 | 0.651+ |
Blood loss(mL)a | 400 | 400 | 300 | 0.025+ |
Transfusion [n (%)] | 28(82.35%) | 5(71.43%) | 55(77.46%) | 0.787 |
Transfusion volume(mL)a | 200 | 200 | 0 | 0.149+ |
Complications [n (%)] | ||||
Pancreatic fistula (BL/A/B/C) | 30/1/1/2 | 4/1/2/0 | 47/5/8/1 | 0.227* |
Delayed gastric emptying | 3(8.82%) | 0 | 3(4.23%) | 0.555* |
Postoperative hemorrhage | 8(23.53%) | 2(28.57%) | 5(7.04%) | 0.035* |
Abdominal infection | 2(5.89%) | 1(14.28%) | 17(23.94%) | 0.075* |
Clavien-Dindo classification [n (%)] | 0.013* | |||
Minor(Grade I and II) | 21(61.76%) | 4(57.14%) | 20(28.17%) | |
Major(Grade III to V) | 8(23.53%) | 2(28.57%) | 24(33.80%) | |
Reoperation [n (%)] | 5(14.71%) | 3(42.86%) | 6(8.45%) | 0.029* |
Death in hospital [n (%)] | 2(5.89%) | 0 | 2(2.82%) | 0.636* |
Hospital stay (day)a | 20 | 21 | 18 | 0.457+ |
ICU stay (day)a | 2 | 0 | 0 | 0.003+ |